Warning: The NCBI web site requires JavaScript to function. more...
Facts, values, and attention-deficit hyperactivity disorder (ADHD): an update on the controversies.
Parens E, Johnston J.
Child Adolesc Psychiatry Ment Health. 2009 Jan 19;3(1):1.
Related citations
Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
[No authors listed]
NIH Consens Statement. 1998 Nov 16-18;16(2):1-37. Review.
[Hearing impairment and psychopathological disorders in children and adolescents. Review of the recent literature].
Bailly D, Dechoulydelenclave MB, Lauwerier L.
Encephale. 2003 Jul-Aug;29(4 Pt 1):329-37. Review. French.
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF, Miller A, Fine S.
Pediatrics. 2004 Nov;114(5):e541-7.
Family pediatrics: report of the Task Force on the Family.
Schor EL; American Academy of Pediatrics Task Force on the Family.
Pediatrics. 2003 Jun;111(6 Pt 2):1541-71.
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM, Earls MF.
Pediatrics. 2005 Jan;115(1):e97-104.
Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics.
Pediatrics. 2000 May;105(5):1158-70. Review.
[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].
Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.
Encephale. 2005 May-Jun;31(3):337-48. Review. French.
[Symptom variations in ADHD: importance of context, development and comorbidity].
Purper-Ouakil D, Wohl M, Michel G, Mouren MC, Gorwood P.
Encephale. 2004 Nov-Dec;30(6):533-9. Review. French.
Special considerations in diagnosing and treating attention-deficit/hyperactivity disorder.
Wigal SB, Wigal TL.
CNS Spectr. 2007 Jun;12(6 Suppl 9):1-14; quiz 15-6. Review.
Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.
Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ.
Pediatrics. 2004 Jul;114(1):e1-8.
Physician perceptions of the use of medications for attention deficit hyperactivity disorder.
Stockl KM, Hughes TE, Jarrar MA, Secnik K, Perwien AR.
J Manag Care Pharm. 2003 Sep-Oct;9(5):416-23.
Emotional and behavioral difficulties and impairments in everyday functioning among children with a history of attention-deficit/hyperactivity disorder.
Strine TW, Lesesne CA, Okoro CA, McGuire LC, Chapman DP, Balluz LS, Mokdad AH.
Prev Chronic Dis. 2006 Apr;3(2):A52. Epub 2006 Mar 15.
Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder.
Arch Gen Psychiatry. 1999 Dec;56(12):1088-96.
Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML; American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.
Pediatrics. 2005 Jun;115(6):e749-57. Review.
Attention deficit hyperactivity disorder: anxiety phenomena in children treated with psychostimulant medication for 6 months or more.
Vance AL, Luk ES, Costin J, Tonge BJ, Pantelis C.
Aust N Z J Psychiatry. 1999 Jun;33(3):399-406.
Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parenting.
Chronis-Tuscano A, Seymour KE, Stein MA, Jones HA, Jiles CD, Rooney ME, Conlon CJ, Efron LA, Wagner SA, Pian J, Robb AS.
J Clin Psychiatry. 2008 Dec;69(12):1938-47. Epub 2008 Dec 2.
Sleep and neurobehavioral characteristics of 5- to 7-year-old children with parentally reported symptoms of attention-deficit/hyperactivity disorder.
O'Brien LM, Holbrook CR, Mervis CB, Klaus CJ, Bruner JL, Raffield TJ, Rutherford J, Mehl RC, Wang M, Tuell A, Hume BC, Gozal D.
Pediatrics. 2003 Mar;111(3):554-63.
Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
Wong IC, Asherson P, Bilbow A, Clifford S, Coghill D, DeSoysa R, Hollis C, McCarthy S, Murray M, Planner C, Potts L, Sayal K, Taylor E.
Health Technol Assess. 2009 Oct;13(50):iii-iv, ix-xi, 1-120.
Social and emotional adjustment in children affected with Gilles de la Tourette's syndrome: associations with ADHD and family functioning. Attention Deficit Hyperactivity Disorder.
Carter AS, O'Donnell DA, Schultz RT, Scahill L, Leckman JF, Pauls DL.
J Child Psychol Psychiatry. 2000 Feb;41(2):215-23.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on